Therefore, when all these results are combined, therapeutic approaches targeting the NOX-NOS axis, a key regulator of the complex crosstalk control among the three elements of metabolism, redox, and inflammation, may open new possibilities for the prevention and treatment of neurodegenerative diseases caused by crosstalk of the liver-brain axis. This evidence concerns the gene NOS1 and neurodegenerative disease.